In a groundbreaking medical first, doctors have restored vision in children who were born almost completely blind. Four young ...
Researchers from London's Moorfields Eye Hospital, biotech firm MeiraGTx and University College London have demonstrated that ...
Researchers from the NIHR Moorfields Biomedical Research Centre and University College London have found that gene therapy improved visual acuity and preserved retinal structure in young children with ...
The vision of one child with AIPL1-associated severe retinal dystrophy improved from light perception to naming his favourite ...
Eleven children who were legally blind at birth all gained visual acuity after receiving MeiraGTx's investigational gene ...
A groundbreaking gene therapy has restored sight in four young children born with severe blindness due to a rare genetic ...
Holdings announced the publication of results from the first-in-human interventional study to treat children with ...
A revolutionary gene therapy treatment in London has improved the vision of children suffering from a rare genetic disorder, ...
Children administered with gene therapy can now see shapes, find toys, and read and write after world-first treatment ...
MeiraGTx Holdings plc announced promising results from a first-in-human study published in The Lancet, involving a gene therapy treatment for children with AIPL1-associated retinal dystrophy ...
The procedure, developed by UCL scientists, consists of injecting healthy copies of the gene into the retina, at the back of ...
Shares of MeiraGTx Holdings shares reached a 52-week high after the company said 11 children treated to date in a drug study gained visual acuity after treatment. The stock was recently up 9.1%, to $7 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback